Company HBM Healthcare Investments AG
Equities
HBMN
CH0012627250
Investment Management & Fund Operators
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
170 CHF | -2.30% | -2.86% | -15.42% |
Dec. 01 | AbbVie to Buy Cancer-focused ImmunoGen for $10.1 Billion | MT |
Nov. 21 | Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation | MT |
Business Summary
Number of employees : 700
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100.0
%
| -74 | 100.0 % | -117 | 100.0 % | +57.95% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| -74 | 100.0 % | -117 | 100.0 % | +57.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andreas Wicki
CEO | Chief Executive Officer | 64 | 2001 |
Erwin Troxler
DFI | Director of Finance/CFO | 53 | 2011 |
Benedikt Suter
SEC | Corporate Secretary | 59 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 2009 | |
Elaine Jones
BRD | Director/Board Member | 68 | 2021 |
Mario Giuliani
BRD | Director/Board Member | 51 | 2011 |
Rudolf Lanz
BRD | Director/Board Member | 73 | 2002 |
Benedikt Suter
SEC | Corporate Secretary | 59 | - |
Stella Xu
BRD | Director/Board Member | 52 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,960,000 | 5,765,405 ( 82.84 %) | 6,570 ( 0.0944 %) | 82.84 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
2,910 | 0.04% | 506,504 $ |
Company contact information

Group companies
Name | Category and Sector |
---|---|
HBM Healthcare Investments (Cayman) Ltd.
|
Health Services - Hospital/Nursing Management
|
HBM Private Equity India
|
Finance - Financial Conglomerates
|
Swixx Biopharma SA
|
Commercial Services - Miscellaneous Commercial Services
|
Sector
Trading Rating :
Investor Rating :
ESG Refinitiv :
D+
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
170CHF
Average target price
236CHF
Spread / Average Target
+38.82%
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.42% | 1 342 M $ | |
-37.60% | 9 147 M $ | |
+16.94% | 2 308 M $ | |
-23.98% | 1 289 M $ | |
+12.41% | 595 M $ | |
+110.05% | 556 M $ | |
-29.02% | 543 M $ | |
+4.13% | 459 M $ | |
+89.07% | 420 M $ | |
+36.24% | 382 M $ |
- Stock
- Equities
- Stock HBM Healthcare Investments AG - Swiss Exchange
- Company HBM Healthcare Investments AG